AtriCure Analyst Price Targets

Wall Street analyst price targets and consensus rating for AtriCure (ATRC).

Price Target Range — 13 Quarters

Analyst Consensus — 10 Analysts

3S.Buy

7Buy

Consensus RatingBuy# Analysts10Avg. Consensus PT$52Upside to Avg. PT+7.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 27, 2026	Piper Sandler	Matt O'Brien	PT Raise	Overweight	$50→$60
Aug 24, 2026	BTIG	Marie Thibault	PT Raise	Buy	$45→$55
Jul 28, 2026	UBS	Priya Sachdeva	PT Cut	Buy	$55→$50
May 6, 2026	Canaccord Genuity	William Plovanic	PT Raise	Buy	$53→$55
Feb 18, 2026	Canaccord Genuity	William Plovanic	PT Cut	Buy	$64→$53
Feb 18, 2026	UBS	Danielle Antalffy	PT Cut	Buy	$60→$55
Feb 18, 2026	Citizens	Daniel Stauder	PT Cut	Market Outperform	$60→$52
Feb 18, 2026	Oppenheimer	Suraj Kalia	Downgrade	Outperform→Perform	—
Feb 18, 2026	BTIG	Marie Thibault	Maintained	Buy	$54
Feb 12, 2026	Needham	Mike Matson	Maintained	Buy	$45
Dec 16, 2025	JP Morgan	Lilia-Celine Lozada	PT Raise	Overweight	$42→$48
Oct 30, 2025	Canaccord Genuity	William Plovanic	PT Raise	Buy	$53→$64
Jul 30, 2025	Needham	Mike Matson	PT Raise	Buy	$44→$45
Apr 30, 2025	BTIG	Marie Thibault	PT Cut	Buy	$58→$52
Apr 30, 2025	UBS	Danielle Antalffy	PT Cut	Buy	$60→$58
Apr 30, 2025	JMP Securities	Daniel Stauder	Maintained	Market Outperform	$60
Apr 30, 2025	Needham	Mike Matson	PT Cut	Buy	$51→$44
Apr 2, 2025	Citizens Capital Markets	Daniel Stauder	Maintained	Market Outperform	$60
Mar 28, 2025	Canaccord Genuity	William Plovanic	PT Cut	Buy	$66→$52
Mar 27, 2025	BTIG	Marie Thibault	PT Raise	Buy	$57→$58